ZETA · Zeta Global Holdings Corp.

The thesis

Zeta Global's AI marketing platform, rebuilt on Palantir Foundry, is being priced as a growth compounder, and analysts keep raising their targets. The third-quarter report, expected around 3 November 2026, decides whether revenue confirms it: management guided $469 million–$472 million on 4 August 2026, and the company has disclosed no revenue from joint Palantir customers. The adjusted close on 22 October 2026 was $33.52, 1.7% below the 52-week high of $34.11.

The narrative is accelerating but is becoming widely held. Benzinga reported on 16 October 2026 that Goldman Sachs upgraded the shares to Buy with a $45 target, and on 12 October 2026 that Roth Capital raised its target to $55. The shares rose 61.6% over three months. The 14-day Relative Strength Index (RSI) is 54.4, down from 62.5 on 9 October 2026, so the move has paused near the high rather than extended.

Bullish and bearish views on Zeta Global Holdings Corp.

The bull case on Zeta Global Holdings Corp. (ZETA), in brief: Reported growth keeps beating guidance. The bear case: Part of headline growth is acquired.

Bull case

• Reported growth keeps beating guidance. Zeta reported second-quarter revenue of $443 million, up 44% year over year, and free cash flow of $58 million, up 73%, on 4 August 2026. Benzinga called it the company's 20th consecutive beat-and-raise quarter. Full-year revenue guidance rose to $1.811 billion–$1.824 billion from $1.779 billion–$1.792 billion, against a $1.787 billion analyst estimate.
• Larger customers are expanding. The 4 August 2026 release counted 197 super-scaled customers and $1.8 million in quarterly average revenue per user, each up 17% year over year.
• Product and data additions arrived in one week. Zeta agreed to buy Senso, an AI engineering firm, on 5 October 2026 and Digital Audience, a data-infrastructure company, on 6 October 2026, with terms undisclosed for both. On 8 October 2026 it announced a collaboration with Fireworks to build the Athena Inference Model on Nvidia Nemotron open models.
• Analyst targets sit above the share price. On 9 October 2026 Needham raised its target to $40, KeyBanc to $38, Truist to $38 and Canaccord Genuity to $37, and RBC Capital reiterated $40 (Benzinga). Goldman Sachs moved to Buy at $45 on 16 October 2026. Benzinga's headline put Roth's target at $55 on 12 October 2026; that figure is the highest reported and was not confirmed in a second source.

Bear case

• Part of headline growth is acquired. The 4 August 2026 guidance put full-year revenue growth at 39%–40%, against 24%–25% excluding mergers, acquisitions and political-candidate revenue. Senso and Digital Audience raise the acquired share again once they close.
• Joint-customer revenue is still undisclosed. Management said on 4 August 2026 that combined-sales agreements with Palantir existed and gave no partnership revenue. Company news through 22 October 2026 names no joint customer with a revenue figure.
• Dilution continues. The company targets 3%–4% net dilution for fiscal 2026. A 11 September 2026 prospectus covered Class A shares to be issued as payment for services.
• Short-seller allegations remain open. Culper Research's 13 November 2024 report alleged consent-farmed data and revenue inflation. Related securities class actions are pending.

Price setup

The adjusted close of $33.52 on 22 October 2026 is 1.7% under the 52-week high of $34.11. Benzinga reported on 16 October 2026 that the shares hit a 52-week high. The shares closed at $29.45 on 25 September 2026, and the $29.62 prior high cited in the 13 September 2026 note is now about 12% below the last close.

Crowding evidence is present. At least eight target increases, reiterations or upgrades landed between 5 October 2026 and 16 October 2026, the three-month gain is 61.6%, and the third-quarter report is expected inside the next 30 days. A Goldman upgrade after a 62% year-to-date advance (Financial Modeling Prep, 9 October 2026 data) means a large part of the good news is already in the price. The consensus target is not available; the individual targets cited here range from $37 to $55.

Catalysts, next 30 days

No upcoming dated catalysts on file — the dated entries below have passed.

Elapsed catalysts

• ~27 October 2026, est.: third-quarter report date. Zeta announced its 2025 date on 20 October 2025; no 2026 announcement was found as of 23 October 2026. (passed 10d ago)
• ~3 November 2026, est.: third-quarter 2026 results. An earnings calendar projects Tuesday 3 November 2026 from past reporting dates; the company has not confirmed it. The test is revenue against the $469 million–$472 million guide, growth excluding acquisitions against the 24%–25% full-year guide, and any quantified Palantir-linked revenue. (passed 3d ago)

What would change the view

The case breaks if third-quarter revenue lands below the $469 million guided floor, or if organic growth falls under the 24%–25% full-year guide while acquired revenue fills the gap. It also weakens if the report again names no Palantir-linked revenue or joint customers after the stock has been priced on that story.

On price, a daily close below $29.62, the prior high cited in the 13 September 2026 note, would return the shares to their late-September range and end the breakout.

What it trades with

Zeta trades with enterprise software and AI-application names, which BofA said on 20 August 2026 were recovering as fears of AI disruption eased. The Palantir link ties part of the story to that company's sentiment. A weak third-quarter report from a large software peer would reach Zeta's shares through the same group.